Search Legislation

Advanced Search

Search Results

Your title search for Clinical Trials Regulations in the English language of legislation from 2004-* has returned 9 results.

  • This is results page 1
Sort ascending by TitleYears and NumbersSort ascending by Legislation type
Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19) (Text with EEA relevance)2020 No. 1043Regulations originating from the EU
Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance)2014 No. 536Regulations originating from the EU
The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 20252025 No. 538UK Statutory Instruments
The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 20192019 No. 744UK Statutory Instruments
The Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 20082008 No. 941UK Statutory Instruments
The Medicines for Human Use (Clinical Trials) Amendment (No.2) Regulations 20062006 No. 2984UK Statutory Instruments
The Medicines for Human Use (Clinical Trials) Amendment Regulations 20062006 No. 1928UK Statutory Instruments
The Medicines for Human Use (Clinical Trials Fees Amendments) Regulations 2004 (revoked)2004 No. 1157UK Statutory Instruments
The Medicines for Human Use (Clinical Trials) Regulations 20042004 No. 1031UK Statutory Instruments
  • This is results page 1

Back to top

The data on this page is available in the alternative data formats listed: